Axonal transport deficits and neurodegenerative diseases
The DOI matches its Crossref record; 179 of the 180 references it cites were found in a registry or an index.
Abstract
The intracellular transport of organelles along an axon is crucial for the maintenance and function of a neuron. Anterograde axonal transport has a role in supplying proteins and lipids to the distal synapse and mitochondria for local energy requirements, whereas retrograde transport is involved in the clearance of misfolded and aggregated proteins from the axon and the intracellular transport of distal trophic signals to the soma. Axonal transport can be affected by alterations to various components of the transport machinery. Here, we review the current state of knowledge about axonal transport defects that might contribute to the pathogenesis of particular neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, tau is also associated with mitochondrial calcium imbalance, and due to the critical role of tau in microtubule structure and function, its abnormal phosphorylation and aggregation may adversely affect mitochondrial axonal transport, impacting local metabolic needs and overall neuronal function.296,297”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [297]
Citations
Cites
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Gauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,177
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Mejzini, R., Flynn, L. L., Pitout, I. L., Fletcher, S., Wilton, S. D., & Akkari, P. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01310 · Cited by 755
Axonal transport: cargo-specific mechanisms of motility and regulation
Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. F. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.019 · Cited by 683
“Further, axonal transport is misregulated in many of the major neurodegenerative diseases affecting human populations, including ALS and Alzheimer’s, Huntington’s, and Parkinson’s diseases (Millecamps and Julien, 2013).”
BackgroundGenome-wide Analyses Identify KIF5A as a Novel ALS Gene
Nicolas, A., Kenna, K. P., Renton, A. E., Ticozzi, N., Faghri, F., Chia, R., Dominov, J. A., Kenna, B. J., Nalls, M. A., Keagle, P., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.02.027 · Cited by 678
Building the Neuronal Microtubule Cytoskeleton
Kapitein, L. C., & Hoogenraad, C. C. (2015) · Neuron · doi:10.1016/j.neuron.2015.05.046 · Cited by 650
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture
Misgeld, T., & Schwarz, T. L. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.055 · Cited by 541
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439
“Thus, features of all three diseases include damage to mitochondria, Ca homeostasis, lipid metabolism, axonal transport, the ER [involving activation of the unfolded protein response (UPR)], autophagy, and also inflammatory responses [5–16].”
BackgroundMAPT mutations, tauopathy, and mechanisms of neurodegeneration
Strang, K. H., Golde, T. E., & Giasson, B. I. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0197-x · Cited by 424
Autophagosome Biogenesis in Primary Neurons Follows an Ordered and Spatially Regulated Pathway
Maday, S., & Holzbaur, E. L. F. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.06.001 · Cited by 372
“Many neurodegenerative disease-associated mutations have been identified in the machinery that transports organelles and proteins across the extended distance of the axon (Millecamps and Julien, 2013; Perlson et al., 2010), emphasizing the unique vulnerability of the neuronal system.”
BackgroundHeinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H. (2017) · Scientific Reports · doi:10.1038/srep45465 · Cited by 334
Axonal transport and neurological disease
Sleigh, J. N., Rossor, A. M., Fellows, A. D., Tosolini, A. P., & Schiavo, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0257-2 · Cited by 316
Axon–soma communication in neuronal injury
Rishal, I., & Fainzilber, M. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3609 · Cited by 286
Retrograde Axonal Degeneration in Parkinson Disease
Tagliaferro, P., & Burke, R. E. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150769 · Cited by 272
“[45] and Millecamps and Julien [46]).”
Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration
Cheng, X.-T., Huang, N., & Sheng, Z.-H. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.015 · Cited by 251
Mechanism and Regulation of Cytoplasmic Dynein
Cianfrocco, M. A., DeSantis, M. E., Leschziner, A. E., & Reck-Peterson, S. L. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125438 · Cited by 244
“Defects in microtubule-based axonal transport are also observed in other neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s, suggesting that there may be additional links between dynein and neurological disease yet to be uncovered (Millecamps & Julien 2013).”
Liu, M., Li, Q., Liang, L., Li, J., Wang, K., Li, J., Lv, M., Chen, N., Song, H., Lee, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15646 · Cited by 243
De Vos, K. J., & Hafezparast, M. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.004 · Cited by 236
“mechanisms underlying motor neuron degeneration have emerged including oxidative stress, mitochondrial dysfunction, misfolded protein toxicity/autophagy defects, RNA toxicity, excitotoxicity, and defective axonal transport (reviewed in Ferraiuolo et al., 2011; De Vos et al., 2008; Millecamps and Julien, 2013).”
Autophagy in Neurodegenerative Diseases: From Mechanism to Therapeutic Approach
Nah, J., Yuan, J., & Jung, Y.-K. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0034 · Cited by 232
“Accordingly, altered activity of the protein degradation system causes the accumulation of abnormal proteins and eventually leads to neuronal dysfunction such as deregulated transcription and impaired axonal transport (Millecamps and Julien, 2013).”
BackgroundMyelin damage and repair in pathologic CNS: challenges and prospects
Alizadeh, A., Dyck, S. M., & Karimi-Abdolrezaee, S. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00035 · Cited by 231
“Axonal transport disturbances are thought to precede the initiation of neurodegeneration in diseases including, hereditary spastic paraplegias (HSPs), AD and Huntington’s disease (Gunawardena et al., 2003; Ebbing et al., 2008; Millecamps and Julien, 2013).”
BackgroundCan We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
Kim, M. J., Kang, J. H., Theotokis, P., Grigoriadis, N., & Petratos, S. (2018) · Cells · doi:10.3390/cells8010001 · Cited by 228
“One of the key initiators of neuronal health is the physiological regulation of fast or slow axonal transport of neurotransmitters and various proteins (and even organelles) central to either growth, plasticity or maintenance of axo-dendritic interaction [81].”
Backgroundvan Beuningen, S. F. B., Will, L., Harterink, M., Chazeau, A., van Battum, E. Y., Frias, C. P., Franker, M. A. M., Katrukha, E. A., Stucchi, R., Vocking, K., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.11.012 · Cited by 225
LaPointe, N. E., Morfini, G., Brady, S. T., Feinstein, S. C., Wilson, L., & Jordan, M. A. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.05.008 · Cited by 219
“The importance of fast axonal transport to neuronal function is highlighted by multiple lines of evidence linking deficits in this process to neurodegeneration (Millecamps and Julien, 2013; Morfini et al., 2009; Perlson et al., 2010).”
Microtubule Minus-End Binding Protein CAMSAP2 Controls Axon Specification and Dendrite Development
Yau, K. W., van Beuningen, S. F. B., Cunha-Ferreira, I., Cloin, B. M. C., van Battum, E. Y., Will, L., Schätzle, P., Tas, R. P., van Krugten, J., Katrukha, E. A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.019 · Cited by 218
Microtubule-based transport – basic mechanisms, traffic rules and role in neurological pathogenesis
Franker, M. A. M., & Hoogenraad, C. C. (2013) · Journal of Cell Science · doi:10.1242/jcs.115030 · Cited by 212
“Disruption of transport is thought to be an early and perhaps causative event in Alzheimer’s disease, Huntington’s disease and ALS, in which abnormal accumulations of cytoskeleton proteins and organelles in axons have been observed (De Vos et al., 2008; Millecamps and Julien, 2013).”
BackgroundRüb, U., Seidel, K., Heinsen, H., Vonsattel, J. P., den Dunnen, W. F., & Korf, H. W. (2016) · Brain Pathology · doi:10.1111/bpa.12426 · Cited by 206
“Although the concept that some human neurodegenerative disorders represent prion-like diseases is currently popular and wellreceived, further studies are necessary to demonstrate that the polyglutamine disease HD is indeed a chronically progredient prionlike protein misfolding disease (9, 11, 21, 39, 53, 57, 60, 64).”
BackgroundInfluentialNeurodegeneration and microtubule dynamics: death by a thousand cuts
Dubey, J., Ratnakaran, N., & Koushika, S. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00343 · Cited by 182
“…Neuroscience | www.frontiersin.org 4 September 2015 | Volume 9 | Article 343 possibility that several of the observed transport defects, in neurodegenerative diseases (De Vos et al., 2008; Millecamps and Julien, 2013), might arise at least in some instances from altered microtubule dynamics.”
BackgroundFluorescent nanodiamonds: past, present, and future
Alkahtani, M. H., Alghannam, F., Jiang, L., Almethen, A., Rampersaud, A. A., Brick, R., Gomes, C. L., Scully, M. O., & Hemmer, P. R. (2018) · Nanophotonics · doi:10.1515/nanoph-2018-0025 · Cited by 180
The axonal cytoskeleton: from organization to function
Kevenaar, J. T., & Hoogenraad, C. C. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00044 · Cited by 178
“…in axonal transport, caused by dysfunctioning or dysregulation of motor proteins, regulatory proteins or the underlying cytoskeleton could all have severe consequences for axonal functioning (Tischfield et al., 2011; Millecamps and Julien, 2013; Niwa et al., 2013; Encalada and Goldstein, 2014).”
BackgroundAn atlas of nano-enabled neural interfaces
Acarón Ledesma, H., Li, X., Carvalho-de-Souza, J. L., Wei, W., Bezanilla, F., & Tian, B. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0487-x · Cited by 178
López-Doménech, G., Higgs, N. F., Vaccaro, V., Roš, H., Arancibia-Cárcamo, I. L., MacAskill, A. F., & Kittler, J. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.004 · Cited by 172
“Axons are up to 104 times longer than dendrites and have often been the focus of attention when studying neurological diseases associated with mutations in transport components (Millecamps and Julien, 2013).”
BackgroundLipka, J., Kapitein, L. C., Jaworski, J., & Hoogenraad, C. C. (2016) · The EMBO Journal · doi:10.15252/embj.201592929 · Cited by 172
“…mechanism of transport is of critical importance since numerous motors and their regulators have been implicated in a wide array of neurodegenerative disorders such as Huntington’s disease, amyotrophic lateral sclerosis and multiple sclerosis (Franker & Hoogenraad, 2013; Millecamps & Julien, 2013).”
Axonal transport defects and neurodegeneration: Molecular mechanisms and therapeutic implications
Guo, W., Stoklund Dittlau, K., & Van Den Bosch, L. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.07.010 · Cited by 169
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
Sorbara, C. D., Wagner, N. E., Ladwig, A., Nikić, I., Merkler, D., Kleele, T., Marinković, P., Naumann, R., Godinho, L., Bareyre, F. M., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.11.006 · Cited by 168
“First, transportdisturbanceshavebeendescribed in several neurodegenerative conditions and appear to precede the initiation of overt neurodegeneration (Millecamps and Julien, 2013).”
ER–mitochondria signaling in Parkinson’s disease
Gómez-Suaga, P., Bravo-San Pedro, J. M., González-Polo, R. A., Fuentes, J. M., & Niso-Santano, M. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0079-3 · Cited by 164
Kononenko, N. L., Claßen, G. A., Kuijpers, M., Puchkov, D., Maritzen, T., Tempes, A., Malik, A. R., Skalecka, A., Bera, S., Jaworski, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14819 · Cited by 164
Autophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells
Ceccariglia, S., Cargnoni, A., Silini, A. R., & Parolini, O. (2020) · Autophagy · doi:10.1080/15548627.2019.1630223 · Cited by 161
“Autophagic impairment causes the aggregation of abnormal and misfolded proteins (such as amyloid-beta in AD, SNCA/alphasynuclein in PD, and mutant HTT [huntingtin] in Huntington disease) leading to neuronal toxicity and dysfunctions such as deregulated transcription and altered axonal transport [26].”
BackgroundTargeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 191
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Ettle, B., Schlachetzki, J. C. M., & Winkler, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9205-3 · Cited by 160
“ropathological features including disturbances in protein homeostasis, mitochondrial functionality, and axonal transport have been proposed, the precise mechanisms eventually leading to neuronal dysfunction and death still remain elusive [1–5].”
BackgroundExcessive tubulin polyglutamylation causes neurodegeneration and perturbs neuronal transport
Magiera, M. M., Bodakuntla, S., Žiak, J., Lacomme, S., Marques Sousa, P., Leboucher, S., Hausrat, T. J., Bosc, C., Andrieux, A., Kneussel, M., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100440 · Cited by 166
“Moreover, organelle accumulations in the degenerating axons are reminiscent of perturbations of axonal transport, which is a common defect in many neurodegenerative disorders (Millecamps & Julien, 2013; Brady & Morfini, 2017).”
Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons
Evans, C. S., & Holzbaur, E. L. (2020) · eLife · doi:10.7554/elife.50260 · Cited by 137
Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease
Cabezas-Opazo, F., Vergara-Pulgar, K., Maria Jose Perez, J., Jara, C., Osorio‐Fuentealba, C., & Quintanilla, R. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509654 · Cited by 167
“Studies in 3xTg-AD mice showed deficits in axonal transport and axonal swelling that precede Aβdeposition or filamentous tau aggregation, suggesting that such deficits might be early events in AD [73].”
BackgroundInfluentialDenton, K. R., Lei, L., Grenier, J. M., Rodionov, V., Blackstone, C. D., & Li, X.-J. (2013) · Stem Cells · doi:10.1002/stem.1569 · Cited by 162
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Chu, Y., Hirst, W. D., Federoff, H. J., Harms, A. S., Stoessl, A. J., & Kordower, J. H. (2023) · Brain · doi:10.1093/brain/awad388 · Cited by 168
“9 Tau inclusions have been found in nigral neurons by direct immuno-chemical studies of partially purified Lewy bodies and indirect immunohistochemical studies.”
BackgroundKoch, J. C., Bitow, F., Haack, J., d’Hedouville, Z., Zhang, J.-N., Tönges, L., Michel, U., Oliveira, L. M. A., Jovin, T. M., Liman, J., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.169 · Cited by 163
“Given the central role of axonal degeneration in PD, it is likely that disturbances of axonal transport are involved.(33)”
BackgroundHaziza, S., Mohan, N., Loe-Mie, Y., Lepagnol-Bestel, A.-M., Massou, S., Adam, M., Xuan, L. L., Viard, J., Plançon, C., Daudin, R., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.260 · Cited by 151
“…inflicting > 1% of the world population) involves a large network of genes displaying subtle changes in their expression 1 Abnormalities in intraneuronal transport have been linked to genetic risk factors found in patients 2,3 , suggesting the relevance of measuring this key biological process.”
Nanowired Bioelectric Interfaces: Focus Review
Tian, B., & Lieber, C. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00795 · Cited by 146
Back to the tubule: microtubule dynamics in Parkinson’s disease
Pellegrini, L., Wetzel, A., Grannò, S., Heaton, G., & Harvey, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2351-6 · Cited by 156
Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS
Trías, E., King, P. H., Si, Y., Kwon, Y., Varela, V., Ibarburu, S., Kovacs, M., Moura, I. C., Beckman, J. S., Hermine, O., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.123249 · Cited by 151
Mechanobiology of the brain in ageing and Alzheimer's disease
Hall, C. M., Moeendarbary, E., & Sheridan, G. K. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14766 · Cited by 149
“However, more severe breakdown in axonal transport machinery occurs in neurodegenerative and neuroinflammatory disorders such as Alzheimer's disease, amyotrophic lateral sclerosis and multiple sclerosis (Li et al., 2011; Millecamps & Julien, 2013; Sorbara et al., 2014).”
BackgroundThe enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases
Lubben, N., Ensink, E., Coetzee, G. A., & Labrie, V. (2021) · Brain Communications · doi:10.1093/braincomms/fcab211 · Cited by 153
“One such study found 64% of a cohort of ALS patients had dominant side onset,134 while another found 70% of patients had dominant side onset.135 It was also shown that the side of limb onset was predictive of the asymmetry of grey matter losses observed in ALS.118 Furthermore, in another study, right-handed patients w…”
BackgroundInfluentialRedistribution of metabolic resources through astrocyte networks mitigates neurodegenerative stress
Cooper, M., Pasini, S., Lambert, W. S., D’Alessandro, K. B., Yao, V., Risner, M. L., & Calkins, D. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009425117 · Cited by 141
“Similar to other neurodegenerative diseases (45, 46), glaucoma involves deficits in axonal anterograde transport to central brain targets.”
ResultGenetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
Suzuki, N., Nishiyama, A., Warita, H., & Aoki, M. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01055-8 · Cited by 158
Loss of tubulin deglutamylase CCP1 causes infantile‐onset neurodegeneration
Shashi, V., Magiera, M. M., Klein, D., Zaki, M., Schoch, K., Rudnik‐Schöneborn, S., Norman, A., Lopes Abath Neto, O., Dusl, M., Yuan, X., et al. (2018) · The EMBO Journal · doi:10.15252/embj.2018100540 · Cited by 133
Carletti, F., Sardo, P., Gambino, G., Liu, X.-A., Ferraro, G., & Rizzo, V. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00029 · Cited by 132
“Disruption of intracellular transport is known to lead to axonal pathologies (Saxena and Caroni, 2007; Perlson et al., 2010; Millecamps and Julien, 2013).”
BackgroundRetinal energy metabolism in health and glaucoma
Casson, R. J., Chidlow, G., Crowston, J. G., Williams, P. A., & Wood, J. P. M. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100881 · Cited by 229
Grantham, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00172 · Cited by 136
“Neurons often display a highly polarized morphology and are therefore especially dependent upon axonal transport to maintain cellular fitness, as components synthesized in the cell body will be required substantial distances away (reviewed by Millecamps and Julien, 2013).”
BackgroundKrauss, R., Bosanac, T., Devraj, R. V., Engber, T. M., & Hughes, R. O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.006 · Cited by 132
Regulation of Axonal Transport by Protein Kinases
Gibbs, K. L., Greensmith, L., & Schiavo, G. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.08.003 · Cited by 126
Cho, B., Choi, S. Y., Cho, H. M., Kim, H. J., & Sun, W. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.149 · Cited by 137
“During the pathological process of ALS, the axonal transport of mitochondria is also impaired in affected motoneuron [72, 73].”
BackgroundMechanisms of Neuronal Homeostasis: Autophagy in the Axon
Maday, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.047 · Cited by 110
“The fact that many models of neurodegenerative disease have defects in retrograde transport (Maday et al., 2014; Millecamps and Julien, 2013) and impaired lysosome function (Gowrishankar et al., 2015; Lee et al., 2010; Xie et al., 2015) suggests that downstream steps in autophagy may be blocked…”
Getting around the cell: physical transport in the intracellular world
Mogre, S. S., Brown, A. I., & Koslover, E. F. (2020) · Physical Biology · doi:10.1088/1478-3975/aba5e5 · Cited by 143
Beckers, J., Tharkeshwar, A. K., & Damme, P. V. (2021) · Autophagy · doi:10.1080/15548627.2021.1872189 · Cited by 143
“diseases underscoring the importance of this mechanism for neuronal maintenance [167,168].”
BackgroundInfluentialGene dosage-dependent rescue of HSP neurite defects in SPG4 patients' neurons
Havlicek, S., Kohl, Z., Mishra, H. K., Prots, I., Eberhardt, E., Denguir, N., Wend, H., Plötz, S., Boyer, L. F., Marchetto, M. C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt644 · Cited by 132
“Alterations in axonal transport are discussed to be a common pathological mechanism not only in several HSPs but also in other neurodegenerative diseases (34).”
BackgroundPrior, R. C., Helleputte, L. V., Benoy, V., & Bosch, L. V. D. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.009 · Cited by 130
Motor neuron mitochondrial dysfunction in spinal muscular atrophy
Miller, N., Shi, H., Zelikovich, A. S., & Ma, Y.-C. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw262 · Cited by 119
“Mitochondria are actively transported by motor proteins kinesin and dynein along cytoskeleton microtubules (29,19).”
BackgroundAxon and dendritic trafficking
Maeder, C. I., Shen, K., & Hoogenraad, C. C. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.03.015 · Cited by 133
“Defects in both axonal and dendritic trafficking is implicated in human neurological disorders and neurodegenerative diseases such as amytrophic lateral sclerosis, Alzeimer’s and Huntington’s disease [51].”
BackgroundDysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia
Pérez‐Brangulí, F., Mishra, H. K., Prots, I., Havlicek, S., Kohl, Z., Saul, D., Rummel, C., Dorca‐Arévalo, J., Regensburger, M., Graef, D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu200 · Cited by 120
“It is well known that the acetylation of tubulin contributes to axonal connectivity by facilitating the stabilization of the microtubules and the recruitment of motor proteins to the tubulin rails (28,29).”
BackgroundMo, Z., Zhao, X., Liu, H., Hu, Q., Chen, X., Pham, J., Wei, N., Liu, Z., Zhou, J., Burgess, R. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03461-z · Cited by 116
Glial Tau Pathology in Tauopathies: Functional Consequences
Kahlson, M. A., & Colodner, K. J. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25515 · Cited by 134
Chemical waves in cell and developmental biology
Deneke, V. E., & Talia, S. D. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201701158 · Cited by 122
“, 2013) and the axonal transport of proteins toward the nerve terminals and back from nerve terminals to the neuron body (Millecamps and Julien, 2013).”
BackgroundBrown, M. R. D., Ramirez, J. D., & Farquhar-Smith, P. W. (2014) · British Journal of Pain · doi:10.1177/2049463714542605 · Cited by 141
KymoAnalyzer : a software tool for the quantitative analysis of intracellular transport in neurons
Neumann, S., Chassefeyre, R., Campbell, G. E., & Encalada, S. E. (2016) · Traffic · doi:10.1111/tra.12456 · Cited by 121
“Finally, the analysis of a previously published movie imaging the movement of a monomeric NeonGreen tagged Kinesin Heavy Chain-1 (KHC (1-560)-mNeGr) recombinant protein, showed that KymoAnalyzer can easily be applied for the characterization of in vitro transport (Figure 9F).”
MethodSilva, D. F., Esteves, A. R., Oliveira, C. R., & Cardoso, S. M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9951-x · Cited by 118
Ren, Z., Wang, C., Wang, T., Ding, H., Zhou, M., Yang, N., Liu, Y., & Chan, P. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0077-8 · Cited by 117
Bicaudal D Family of Motor Adaptors: Linking Dynein Motility to Cargo Binding
Hoogenraad, C. C., & Akhmanova, A. S. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.001 · Cited by 119
Hitchhiking: A Non-Canonical Mode of Microtubule-Based Transport
Salogiannis, J., & Reck‐Peterson, S. L. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.09.005 · Cited by 113
Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons
Nieweg, K., Andreyeva, A., van Stegen, B., Tanriöver, G., & Gottmann, K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.72 · Cited by 115
Yoon, W. H., Sandoval, H., Nagarkar-Jaiswal, S., Jaiswal, M., Yamamoto, S., Haelterman, N. A. T., Putluri, N., Putluri, V., Sreekumar, A., Tos, T., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.11.038 · Cited by 114
Esteves, A. R., Palma, A. M., Gomes, R., Santos, D., Silva, D. F., & Cardoso, S. M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.014 · Cited by 103
Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms
Evans, C. S., & Holzbaur, E. L. F. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.031 · Cited by 110
“strong genetic evidence linking mutations in intracellular trafficking proteins to a range of neurodegenerative diseases [1].”
BackgroundMilde, S., Adalbert, R., Elaman, M. H., & Coleman, M. P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.018 · Cited by 117
“However, many age-associated neurodegenerative conditions affect the CNS (Adalbert and Coleman, 2013; Millecamps and Julien, 2013), highlighting the need to understand howaging affects the function of CNS neurons, including their axonal transport.”
InfluentialALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
Baron, D. M., Fenton, A. R., Sáez-Atiénzar, S., Giampetruzzi, A., Sreeram, A., Shankaracharya, Keagle, P. J., Doocy, V. R., Smith, N. J., Danielson, E., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110598 · Cited by 107
Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS
Gibbs, K. L., Kalmár, B., Rhymes, E. R., Fellows, A. D., Ahmed, M., Whiting, P. J., Davies, C. H., Greensmith, L., & Schiavo, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0624-8 · Cited by 106
DCTN1-related neurodegeneration: Perry syndrome and beyond
Konno, T., Ross, O. A., Teive, H. A. G., Sławek, J. W., Dickson, D. W., & Wszołek, Z. K. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.06.004 · Cited by 104
“Deficits in axonal transport contribute to several neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease (PD), Huntington’s disease (HD), hereditary neuropathies, and motor-neuron diseases [2].”
BackgroundLipka, J., Kuijpers, M., Jaworski, J., & Hoogenraad, C. C. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130188 · Cited by 108
Synaptic plasticity in Alzheimer’s disease and healthy aging
Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 104
Gene Therapy for ALS—A Perspective
Cappella, M., Ciotti, C., Cohen-Tannoudji, M., & Biferi, M. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184388 · Cited by 110
“However, the intramuscular delivery of viral vectors could be likely impaired by neuromuscular denervation and defective axonal transport, typical signs observed in ALS [73,96].”
BackgroundA PIK3C3–Ankyrin-B–Dynactin pathway promotes axonal growth and multiorganelle transport
Lorenzo, D. N., Badea, A., Davis, J. Q., Hostettler, J., He, J., Zhong, G., Zhuang, X., & Bennett, V. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201407063 · Cited by 106
“JCB: Article”
Smith, G. A., Rocha, E. M., McLean, J. R., Hayes, M. A., Izen, S. C., Isacson, O., & Hallett, P. J. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu166 · Cited by 103
Ionescu, A., Gradus, T., Altman, T., Maimon, R., Avraham, N. S., Geva, M., Hayden, M. R., & Perlson, E. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1451-2 · Cited by 102
Biophysical Challenges to Axonal Transport: Motor-Cargo Deficiencies and Neurodegeneration
Encalada, S. E., & Goldstein, L. S. B. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022746 · Cited by 102
“Axonal transport deficits appear to be a general feature of neurodegenerative diseases (100).”
BackgroundInfluentialFumagalli, L., Young, F. L., Boeynaems, S., Decker, M. D., Mehta, A. R., Swijsen, A., Fazal, R., Guo, W., Moisse, M., Beckers, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3013 · Cited by 97
“Defective microtubule-based transport of mitochondria in axons has been linked with a variety of neurodegenerative diseases (43), including ALS caused by other mutations (44–48).”
BackgroundNardo, G., Iennaco, R., Fusi, N., Heath, P. R., Marino, M., Trolese, M. C., Ferraiuolo, L., Lawrence, N. D., Shaw, P. J., & Bendotti, C. (2013) · Brain · doi:10.1093/brain/awt250 · Cited by 102
Yuan, X., Schröter, M. S., Obien, M. E. J., Michele, F., Gong, W., Kikuchi, T., Odawara, A., Noji, S., Suzuki, I., Takahashi, J. B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18620-4 · Cited by 97
Genetics of Amyotrophic Lateral Sclerosis
Gregory, J. M., Fagegaltier, D., Phatnani, H., & Harms, M. B. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00194-8 · Cited by 83
Smit-Rigter, L., Rajendran, R., Silva, C. A. P., Spierenburg, L., Groeneweg, F., Ruimschotel, E. M., van Versendaal, D., van der Togt, C., Eysel, U. T., Heimel, J. A., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.033 · Cited by 91
Metadata
- Authors
- Millecamps, S., & Julien, J.-P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Centre hospitalier universitaire de Québec (CA)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- Nature Reviews Neuroscience
- Published
- 2013-01-30
- Volume
- 14
- Issue
- 3
- Pages
- 161-176
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2006524711
- Cited by
- 755
- References
- 180
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 46 · 2023: 51 · 2022: 70 · 2021: 57 · 2020: 61 · 2019: 60 · 2018: 60 · 2017: 67 · 2016: 79 · 2015: 63 · 2014: 45 · 2013: 22
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- axonal transport, neurodegenerative diseases, microtubule transport, anterograde transport, retrograde transport, mitochondrial transport, protein aggregate clearance, synapse maintenance, pathogenesis
- MeSH terms
- Animals, Axonal Transport, Humans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.